Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 14
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
11/1/1997
1.
Phase II/III Pilot Treatment of Pediatric Non-B, Non-T ALL in First Marrow Relapse (SIMAL #8): Intensive Re-Induction and Reconsolidation Chemotherapy with Subsequent Myeloablative Chemoradiotherapy and Rescue with Either Allogeneic or In Vitro-Purged Autologous Marrow (Summary Last Modified 11/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
under 21 at relapse
NCI
POG-9410
POG-SIMAL-8
Last Modified:
1/1/1999
2.
Phase III Randomized Study of Anti-B4-Blocked Ricin as Adjuvant Therapy for Patients in CR Following Marrow Ablation and Autologous Rescue for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (Summary Last Modified 01/99)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
physiologic age 18 to 65
NCI
CLB-9254
E-C9254, CALGB-9254
Last Modified:
12/1/1992
3.
Phase I/II Study of MOAB Anti-B4/Blocked Ricin Immunoconjugate Given by Continuous Infusion in Patients with B-Cell Leukemias and Lymphomas (Summary Last Modified 12/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
physiologic 18 to 74
DFCI-90147
NCI-V91-0144
Last Modified:
10/1/1994
4.
Phase II Study of Anti-B4-bR Immunoconjugate in Relapsed/Refractory Hairy Cell Leukemia (Summary Last Modified 10/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 to physiologic 64
NCI
NU-T93-0040
NCI-T93-0040O, T93-0040
Last Modified:
5/1/1997
5.
Phase II Study of Sequential Anti-B4-bR and EPOCH for Refractory B-Cell non-Hodgkin's Lymphoma (Summary Last Modified 05/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
physiologic 18 to 65
Other
DFCI-94025
NCI-V94-0582
Last Modified:
11/1/1992
6.
Phase II Study of Anti-B4/Blocked-Ricin Conjugate in Patients with B-Cell Leukemia (Summary Last Modified 11/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
BRMP-9106B
NCI-91-C-222B, NCI-T91-0166N, T91-0166
Last Modified:
9/1/1992
7.
Phase II Study of ProMACE-CytaBOM (PRED/CTX/DOX/ARA-C/BLEO/VCR/MTX) and VP-16 Followed by MOAB Anti-B4/Blocked Ricin Immunoconjugate in Adults with Low-Grade and Selected Intermediate-Grade Lymphomas (Summary Last Modified 09/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
BRMP-9110
NCI-92-C-0203
Last Modified:
7/1/1994
8.
Phase II Feasibility Study of Lineage-Specific Consolidation Therapy for Adult ALL Early in First Remission: Anti-B4-bR for B-Lineage ALL and High-Dose ARA-C for non-B-Lineage ALL (Summary Last Modified 07/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
15 and over
NCI
CLB-9311
CALGB-9311
Last Modified:
3/1/1995
9.
Phase I Study of Autologous BMT with Anti-B4-bR-Treated Bone Marrow for Acute Lymphocytic Leukemia in Remission (Summary Last Modified 03/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 to 50
DFCI-90039
NCI-V94-0579
Last Modified:
7/1/1990
10.
Phase I Study of Immunotherapy with Continuous-Infusion Anti-B4/Blocked-Ricin Conjugate in Patients with B-Cell Leukemia or Lymphoma (Summary Last Modified 07/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 18 and under 65
DFCI-89078
NCI-V90-0069
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute